CorMedix (CRMD) Share-based Compensation (2010 - 2025)

CorMedix (CRMD) has 14 years of Share-based Compensation data on file, last reported at $3.6 million in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation rose 200.71% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $8.7 million (up 129.7% YoY), and the FY2025 full-year result was $14.3 million, up 133.32% from the prior year.
• Share-based Compensation rose to $3.6 million in Q4 2025, from $3.3 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.2 million in Q1 2025 to a low of -$4.1 million in Q4 2023.
• A 5-year average of $1.5 million and a median of $1.2 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 566.57% in 2023 and surged 5229.6% in 2025, its largest moves.
• Tracing CRMD's Share-based Compensation over 5 years: stood at $4.1 million in 2021, then plunged by 78.75% to $874051.0 in 2022, then tumbled by 566.57% to -$4.1 million in 2023, then surged by 129.27% to $1.2 million in 2024, then jumped by 200.71% to $3.6 million in 2025.
• Business Quant data shows CRMD's Share-based Compensation at $3.6 million in Q4 2025, $3.3 million in Q3 2025, and $2.7 million in Q2 2025.